atezolizumab,tiragolumab,etoposide,carboplatin
roche
['tiragolumab', 'skyscraper-02', 'atezo', 'sclc']
#asco22 june 5, 9:45 am ct, arie crown theater: lcrf scientific advisory board member dr. charles rudin will present skyscraper-02: results of a phase 3 study of atezolizumab + carboplatin + etoposide with or without tiragolumab in sclc. 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.